Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2021-3160
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Deserialization of untrusted data in the login page of ASSUWEB 359.3 build 1 subcomponent of ACA ASSUREX RENTES product allows a remote attacker to inject unsecure serialized Java object using a specially crafted HTTP request, resulting in an unauthenticated remote code execution on the server.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Aca Assurex Rentes 代码问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Aca Assurex Rentes是法国Aca公司的一个用于管理所有类型资金的Saas服务。该服务涵盖了年金合同的整个生命周期:清算,计算模拟,定价,欠款计算,付款,重估,理据,数学规定的计算,社会保障缴款的计算,纳税申报,死亡和还原。存储库和业务规则可以由业务用户直接配置。 Aca Assurex Rentes ASSUWEB 359.3 存在代码问题漏洞,该漏洞允许远程攻击者通过一个特别制作的HTTP请求注入不安全的序列化Java对象。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2021-3160
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2021-3160
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2021-3160

No comments yet


Leave a comment